Jiang, Lavender Yao http://orcid.org/0000-0003-2464-3281
Liu, Xujin Chris
Nejatian, Nima Pour
Nasir-Moin, Mustafa http://orcid.org/0000-0002-0389-1852
Wang, Duo
Abidin, Anas http://orcid.org/0000-0003-0032-0664
Eaton, Kevin
Riina, Howard Antony
Laufer, Ilya
Punjabi, Paawan
Miceli, Madeline
Kim, Nora C.
Orillac, Cordelia
Schnurman, Zane
Livia, Christopher
Weiss, Hannah
Kurland, David http://orcid.org/0000-0002-4074-7497
Neifert, Sean
Dastagirzada, Yosef http://orcid.org/0009-0003-3237-6037
Kondziolka, Douglas
Cheung, Alexander T. M. http://orcid.org/0000-0003-0946-3493
Yang, Grace
Cao, Ming
Flores, Mona http://orcid.org/0000-0002-7362-3044
Costa, Anthony B.
Aphinyanaphongs, Yindalon
Cho, Kyunghyun
Oermann, Eric Karl http://orcid.org/0000-0002-1876-5963
Article History
Received: 14 October 2022
Accepted: 2 May 2023
First Online: 7 June 2023
Change Date: 4 July 2023
Change Type: Update
Change Details: In the version of this article initially published, the graphs in Fig. 2b and Fig. 2c were interchanged, while there were additional patient icons shown in Fig. 4b; the correct figure versions are now shown in the HTML and PDF versions of the article.
Competing interests
: E.K.O. reports consulting with Sofinnova and Google, income from Merck & Co. and Mirati Therapeutics, and equity in Artisight. N.P.N., M.F. and A.B.C. are employed by NVIDIA. D.K. reports consulting with Elekta. K.C. is employed by Prescient Design, a Genentech accelerator, a subsidiary of Roche. There are no other potential conflicts of interest. The work presented herein was performed exclusively within the NYU Langone Health System.